According to RVL Pharmaceuticals's latest financial reports the company's current revenue (TTM) is A$55.37 M. In 2022 the company made a revenue of A$73.06 M an increase over the revenue in the year 2021 that were of A$55.62 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.